**Summary of Reckitt Q3 2025 Trading Update**
Reckitt Benckiser Group PLC reported strong Q3 2025 results, with **Core Reckitt** delivering **6.7% like-for-like (LFL) net revenue growth**, driven by robust performance in **Emerging Markets** (+15.5% LFL) and a return to growth in **Developed Markets** (Europe +0.8%, North America +1.3%). The company highlighted **volume improvements** (+3.4% in Core Reckitt) and the strength of its **Powerbrands**, particularly in **Intimate Wellness** (+13.5% LFL) and **Germ Protection** (+9.2% LFL).
**Key Highlights**
1. **Emerging Markets** led growth, with China delivering double-digit gains across categories like **Dettol**, **Durex**, and **Intima**. India saw low single-digit growth due to a GST regime shift, but remains high single-digit YTD.
2. **Europe** returned to growth (+0.8% LFL) with innovations driving premiumisation and volume recovery.
3. **North America** grew +1.3% LFL, excluding seasonal OTC brands, with **Lysol** and **Neuriva** performing well.
4. **Mead Johnson Nutrition** rebounded strongly (+22.0% LFL) after recovering from the 2024 tornado impact.
5. **Essential Home** declined (-4.9% LFL) due to weak performance in Brazil and U.S. Air Care, with divestment expected by December 2025.
**Strategic Progress**
**ยฃ1 billion share buyback** commenced, with the first ยฃ250m tranche completed.
Balanced growth algorithm with volume (+3.4%) and price/mix (+3.3%) contributions.
Innovations like **Mucinex Rapid+Clear** and **Durex Intensity** drove growth.
**Outlook**
FY 2025 guidance maintained**Group LFL net revenue growth of 3-4%**, with Core Reckitt <mark style="background-color:yellow">above</mark> 4%.
Adjusted operating profit expected to outpace net revenue growth, supported by the **Fuel for Growth** programme.
Adjusted diluted EPS growth anticipated for the year.
Reckitt remains confident in its strategy to deliver sustainable growth as a global leader in consumer health and hygiene.
Hereโs an HTML table comparing the year-on-year financials and debt for Reckitt Benckiser Group PLC based on the provided text. The table focuses on key financial metrics for Q3 and YTD 2025 compared to 2024, including net revenue, volume, price/mix, and LFL growth.
### Notes:
1. **Debt Information**: The provided text does not include specific debt figures for comparison. If debt details were available, they could be added as additional rows in the table.
2. **LFL Growth**: Like-for-Like (LFL) growth is provided where available in the text.
3. **IFRS**: International Financial Reporting Standards (IFRS) figures are used for net revenue comparisons. This table provides a clear year-on-year comparison of key financial metrics for Reckitt Benckiser Group PLC.